PubMed:32514935 / 766-937
Annnotations
LitCovid-OGER-BB
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T31 | 81-96 | CHEBI:52217 | denotes | pharmacotherapy |
| T32 | 81-96 | CHEBI:52217 | denotes | pharmacotherapy |
| T33 | 100-108 | SP_7 | denotes | COVID-19 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T13 | 77-80 | Disease | denotes | ARB | http://purl.obolibrary.org/obo/MONDO_0012733 |
| T14 | 100-108 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T6 | 0-171 | Sentence | denotes | In this point of view paper, possible scenarios regarding the impact of ACEI/ARB pharmacotherapy on COVID-19 are discussed in relation to the currently available evidence. |